MANKIND PHARMA

Lupin Pharmaceuticals plans to launch generic GLP-1 receptor agonists in 2026, targeting India, South Africa, Latin America, the Philippines, and Eastern Europe. The company aims to capitalize on patent expiries by combining in-house development with licensing partnerships. Competitors like Cipla, Dr. Reddy’s, Wockhardt, and Mankind Pharma are also entering the GLP-1 market, driven by high demand for diabetes and obesity treatments.

Keytruda, a cancer drug, achieved $25 billion in global sales, treating 40 cancers in the US and 17 in India. Its mechanism activates the immune system to fight cancer cells, categorized as immunotherapy. Despite high costs, it has shown remarkable results in some cases, prompting Indian drugmakers to develop affordable biosimilars as patents expire.

Metropolis Healthcare Limited launches Metropolis Institute of Laboratory Education and Skilling (MiLES) in partnership with DY Patil University, offering specialized Fellowship programs to bridge the gap between academic learning and practical skills in healthcare.

Mankind Pharma launches RAPID NEWS self-test kits for dengue, UTIs, and menopause, aiming to provide accessible, private, and rapid testing solutions in India.

HFCL partners with GA-ASI for UAS sub-systems, Dreamfolks Services addresses disruption, Sterling and Wilson Renewable Energy CFO resigns, Ugro Capital postpones board meeting, Aster DM Healthcare leases land for new hospital, Vodafone Idea signs $3.6 billion network deal, ONGC Videsh secures gas deal in Azerbaijan, USFDA inspects Glenmark Pharmaceuticals with no observations, Ramco Cements expands capacity, BHEL awarded NTPC contract, Reliance Industries extends call money payment deadline, USFDA inspects Aarti Drugs with Form 483 observations, Tata Steel commissions India’s largest blast furnace, Avalon Technologies CFO resigns, USFDA inspects Dr Reddy’s Laboratories with zero observations, HDFC Bank approves HDB Financial Services IPO, Bharat Forge enters renewable energy agreement, Signature Global CFO resigns, JM Financial reappoints and appoints MDs, Adani Total Gas secures international financing, Godfrey Phillips India considers bonus shares, Mankind Pharma approves fund raising, Vanguard Group Inc buys stakes in various companies.

The article discusses the importance of SSR (Server-Side Rendering) in web development for improving performance and SEO.

India, known as the 'Pharmacy of the World,' supplied vaccines and medicines globally during COVID-19, fulfilling 40% of U.S. generic drug demand and 25% of U.K. medicines. The $50 billion industry is projected to grow to $130 billion by 2030, driven by companies like Mankind Pharma, which acquired Bharat Serums and Vaccines for ₹13,600 crore. India faces regulatory challenges including complex drug approvals, IP issues, and API dependency, necessitating reforms like streamlined approval processes and boosting API self-sufficiency.

India, known as the 'Pharmacy of the World,' supplied vaccines and medicines globally during COVID-19, fulfilling 40% of U.S. generic drug demand and 25% of U.K. medicines. Mankind Pharma, a key player, expanded through strategic acquisitions. India's pharma industry faces regulatory challenges like complex approvals and API dependency, but reforms like streamlined processes and expanded PLI schemes could boost growth.